Can you advise whether PSMA (Prostate Specific Membrane Antigen) PET-CT is funded by the DHB, or only available privately?
If publicly funded, please can you advise whether there are criteria that must be met. For example: For staging of high risk and unfavourable intermediate risk prostate cancer before definitive local therapy. For restaging of PSA recurrence (≥0.2ng/ml).
Please provide the Letter of Understanding between the DHB and the PSA regarding an increase of penal rates for PSA members, effective 13/4/2020. clarified as referring to all DHBs that employ laboratory workers.